Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Investing Pro 0
Ad-Free Version. Upgrade your experience. Save up to 40% More details

The Cooper Companies At 52-Week High On Strong Portfolio

By Zacks Investment ResearchStock MarketsSep 15, 2016 09:53PM ET
The Cooper Companies At 52-Week High On Strong Portfolio
By Zacks Investment Research   |  Sep 15, 2016 09:53PM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items

Share price of The Cooper Companies (NYSE:COO) rallied to a new 52-week high of $190.75 on Sep 15, eventually closing a tad lower at $189.90. This represents a strong year-to-date return of approximately 41.5%, better than the S&P 500’s 5% over the same time frame.

Currently, Cooper Companies carries a Zacks Rank #3 (Hold). The stock has a market cap of $9.04 billion and long-term expected earnings growth rate of 11.8%.

Growth Catalysts

A solid product pipeline is a major positive for the company in our view. Especially, the launch of Avaira Vitality in the U.S. buoys optimism as the product is expected to drive margins over the long haul. Additionally, the rollout of MyDay in Japan is a noteworthy development as it is expected to fortify the company’s market position.

Meanwhile, we note that each and every business segment of the company contributed toward the current growth trend. The CooperVision segment (CVI) of the company posted a stellar performance in the last-reported third quarter of 2016, raking in revenues of $409.9 million (up 6% at constant currency). Particularly, the Toric, Multifocal and Sphere lenses deserve special mention here. The CooperSurgical (CSI) unit of the company performed exceptionally well as well, enhancing the growth trajectory.

COOPER COS Price and Consensus

COOPER COS Price and Consensus | COOPER COS Quote

In this regard, Cooper Companies reported an impressive third quarter of 2016 with revenues of $514.7 million improving 6% year over year at constant currency. Notably, adjusted earnings of $2.30 per share beat the Zacks Consensus Estimate by 2 cents, up 16.8% on a year-over-year basis.

Estimate Revisions

The company’s current year estimate revision trend is also looking quite promising with 8 estimates moving higher over the past two months, compared to one downward revision. The consensus estimate trend has also seen a boost for this time frame, increasing by 3 cents to $8.41 per share.

Key Picks

Better-ranked stocks in the broad medical sector include Halyard Health Inc (NYSE:HYH) , INC Research Holdings Inc. (NASDAQ:INCR) and Lonza Group Limited (OTC:LZAGY) . Notably, all the companies sport a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Confidential from Zacks

Beyond this Analyst Blog, would you like to see Zacks' best recommendations that are not available to the public? Our Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand. Click to see them now>>

COOPER COS (COO): Free Stock Analysis Report

HALYARD HEALTH (HYH): Free Stock Analysis Report

INC RESRCH HLDG (INCR): Free Stock Analysis Report

LONZA GROUP AG (LZAGY): Free Stock Analysis Report

Original post

Zacks Investment Research
The Cooper Companies At 52-Week High On Strong Portfolio

Related Articles

The Cooper Companies At 52-Week High On Strong Portfolio

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at’s discretion.

Write your thoughts here
Are you sure you want to delete this chart?
Post also to:
Replace the attached chart with a new chart ?
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Are you sure you want to delete this chart?
Replace the attached chart with a new chart ?
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
Sign up with Email